CNTB
Connect Biopharma Holdings Ltd
Key Financials
Revenue
$64000
↓ 99.8%
Operating Income
$-58074000
↓ 158.7%
Net Income
$-55480000
↓ 255.0%
Total Assets
$56.1M
↓ 44.6%
Cash & Equivalents
$38.3M
↓ 51.0%
Total Liabilities
$14.1M
↑ 54.6%
EPS (Diluted)
$-1.00
↓ 257.1%
Shareholders' Equity
$42.0M
↓ 54.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/1/2026 | View on SEC |
| 4 | 10/1/2026 | View on SEC |
| 8-K | 9/30/2026 | View on SEC |
| 8-K | 9/15/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| 8-K | 8/12/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CNTB |
| Company Name | Connect Biopharma Holdings Ltd |
| CIK | 1835268 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 858-727-1040 |